Search Results - "Hexner EO"

Systemic steroid treatment of grade I acute GVHD increases steroid-refractory GVHD and NRM.

Authors: Akahoshi Y Katsivelos N Louloudis IE et al.

Source: Blood immunology & cellular therapy [Blood Immunol Cell Ther] 2026 Jun; Vol. 2 (2). Date of Electronic Publication: 2026 Apr 29.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9919050937306676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 3050-5976 (Electronic) Linking ISSN: 30505976 NLM ISO Abbreviation: Blood Immunol Cell Ther Subsets: PubMed not MEDLINE

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Authors: Gotlib J Reiter A Radia DH et al.

Source: Blood advances [Blood Adv] 2026 May 26; Vol. 10 (10), pp. 3676-3689.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.

Authors: Xu J McCoy M Martinez Z et al.

Source: Blood advances [Blood Adv] 2026 Apr 28; Vol. 10 (8), pp. 2676-2686.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Authors: Chen GM Jain A Gering DT et al.

Source: Nature biomedical engineering [Nat Biomed Eng] 2026 Apr; Vol. 10 (4), pp. 803-814. Date of Electronic Publication: 2026 Mar 09.

Publication Type: Journal Article

Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE

Update in GVHD Prophylaxis: Novel Pharmacologic and Graft Manipulation Strategies.

Authors: Hexner EO DeFilipp Z

Source: American journal of hematology [Am J Hematol] 2025 May; Vol. 100 Suppl 3, pp. 30-39.

Publication Type: Journal Article; Review

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

NCI Awardee Skills Development Consortium (NASDC): a Successful Novel Educational Effort to Maintain Early Academic Competitiveness: PART 1-Overview of the NASDC Coordinating Center.

Authors: Verschraegen CF Hashibe M Neill US et al.

Corporate Authors: Verschraegen CF Hashibe M Neill US et al.

Source: Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2026 Mar; Vol. 41 (1), pp. 143-155. Date of Electronic Publication: 2025 Jun 10.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: England NLM ID: 8610343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-0154 (Electronic) Linking ISSN: 08858195 NLM ISO Abbreviation: J Cancer Educ Subsets: MEDLINE

Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus.

Authors: Salit RB Hexner EO Gagelmann N et al.

Source: Leukemia [Leukemia] 2025 Dec; Vol. 39 (12), pp. 2862-2865. Date of Electronic Publication: 2025 Oct 13.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; In Process

The MAGIC composite response: a novel end point integrating clinical and biomarker parameters for acute GVHD.

Authors: Akahoshi Y Portelli J Katsivelos N et al.

Source: Blood advances [Blood Adv] 2025 Nov 25; Vol. 9 (22), pp. 5763-5773.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.

Authors: Chippendale L Freyer CW Carulli A et al.

Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Jul; Vol. 30 (5), pp. 802-810. Date of Electronic Publication: 2023 Aug 21.

Publication Type: Journal Article; Comparative Study

Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE

Refinement of day 28 treatment response criteria for acute GVHD: a collaboration study of the JSTCT and MAGIC.

Authors: Akahoshi Y Inamoto Y Spyrou N et al.

Source: Blood advances [Blood Adv] 2025 Sep 23; Vol. 9 (18), pp. 4640-4653.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Clinical and molecular dissection of CAR T cell resistance in pancreatic cancer.

Authors: Aznar MA Good CR Barber-Rotenberg JS et al.

Source: Cell reports. Medicine [Cell Rep Med] 2025 Sep 16; Vol. 6 (9), pp. 102301. Date of Electronic Publication: 2025 Aug 18.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Author Correction: Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.

Authors: Bagley SJ Desai AS Fraietta JA et al.

Source: Nature medicine [Nat Med] 2025 Sep; Vol. 31 (9), pp. 3205.

Publication Type: Published Erratum

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process

Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial.

Authors: Bagley SJ Desai AS Fraietta JA et al.

Source: Nature medicine [Nat Med] 2025 Aug; Vol. 31 (8), pp. 2778-2787. Date of Electronic Publication: 2025 Jun 01.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Characterization of the calcineurin inhibitor pain syndrome in patients undergoing allogeneic hematopoietic cell transplantation.

Authors: Freyer CW Carulli A Frey NV et al.

Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Feb; Vol. 65 (2), pp. 250-256. Date of Electronic Publication: 2024 Jan 24.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy.

Authors: Myers RM DiNofia AM Li Y et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Apr 17; Vol. 13 (4). Date of Electronic Publication: 2025 Apr 17.

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Inconsistent Reporting and Definitions of Time-to-Event Endpoints in CAR T Clinical Trials: A Review.

Authors: Grady CB Li Y Maude SL et al.

Source: Transplantation and cellular therapy [Transplant Cell Ther] 2025 Apr; Vol. 31 (4), pp. 271.e1-271.e13. Date of Electronic Publication: 2024 Nov 26.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.

Authors: Jadlowsky JK Hexner EO Marshall A et al.

Source: Nature medicine [Nat Med] 2025 Apr; Vol. 31 (4), pp. 1134-1144. Date of Electronic Publication: 2025 Jan 20.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.

Authors: Matthews AH Perl AE Luger SM et al.

Source: American journal of hematology [Am J Hematol] 2023 Aug; Vol. 98 (8), pp. 1254-1264. Date of Electronic Publication: 2023 Jun 19.

Publication Type: Multicenter Study; Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

Evolving racial/ethnic disparities in AML survival in the novel therapy era.

Authors: Wang X Gimotty PA Matthews AH et al.

Source: Blood advances [Blood Adv] 2025 Feb 11; Vol. 9 (3), pp. 533-544.

Publication Type: Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Ruxolitinib and exemestane for estrogen receptor positive, aromatase inhibitor resistant advanced breast cancer.

Authors: Makhlin I McAndrew NP Wileyto EP et al.

Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Nov 11; Vol. 8 (1), pp. 122. Date of Electronic Publication: 2022 Nov 11.

Publication Type: Journal Article

Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE